发明名称 FIBRIN SEALING COMPOSITION AND METHOD FOR USING IT
摘要 PURPOSE: To form a fibrin sealant which is safe without the contamination with viruses, etc., by bringing a fibrin monomer-contg. compsn. into contact with the section desired to be stanched, etc., and simultaneously converting the fibrin monomer to a fibrin polymer. CONSTITUTION: The compsn. contg. the fibrin monomer (more adequately fibrin enomoner) is brought into contact with the desired section, such as the section to be stanched or the sutured section of tissues and simultaneously the fibrin monomer is converted to the fibrin polymer preferably before 3 seconds of the contact and within 0.5 minutes after the contact. The conversion of the fibrin monomer to the fibrin polymer is executed by bringing an alkaline buffer soln., such as 0.5 to 0.75 M sodium carbonate/sodium bicarbonate, into contact with the compsn. described above in the case the fibrin monomer is obtd. by solubilizing, for example, the non-cross-linked fibrin obtd. from the blood with the acid buffer soln. The non-cross-linked fibrin is preferably obtd. by acting thrombin-like enzyme on plasma. This enzyme is preferably battroxobin.
申请公布号 JPH06199685(A) 申请公布日期 1994.07.19
申请号 JP19930284097 申请日期 1993.10.08
申请人 BRISTOL MYERS SQUIBB CO 发明人 PIITAA ANDORIYUU DEIBITSUDO EDOWAADOSON;JIYON ESAMU FUEABURAZAA;RONARUDO SUTEFUEN GAADONAA;DEREKU ANDORIYUU HORINGUSUBII;SUCHIYUAATO ANSONII SEDAHORUMUUUIRIAMUZU
分类号 A61K35/14;A61K33/06;A61K38/00;A61K38/17;A61K38/36;A61K38/39;A61K38/45;A61K38/48;A61L15/32;A61L17/00;A61L24/00;A61L24/10;A61L27/22;A61L31/00;A61P7/04;C07K1/00;C07K14/00;C07K14/75;C07K16/00;C12N11/06;C12N11/10;G01N33/86 主分类号 A61K35/14
代理机构 代理人
主权项
地址